• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ofatumumab in rituximab-refractory autoimmune hemolytic anemia associated with chronic lymphocytic leukemia: a case report and review of literature.

作者信息

Nader Kamyar, Patel Monaliben, Ferber Andres

机构信息

Department of Internal Medicine, Cooper University Hospital, Camden, NJ, USA.

出版信息

Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):511-3. doi: 10.1016/j.clml.2013.02.022. Epub 2013 May 29.

DOI:10.1016/j.clml.2013.02.022
PMID:23726016
Abstract
摘要

相似文献

1
Ofatumumab in rituximab-refractory autoimmune hemolytic anemia associated with chronic lymphocytic leukemia: a case report and review of literature.奥法木单抗治疗与慢性淋巴细胞白血病相关的利妥昔单抗难治性自身免疫性溶血性贫血：一例报告并文献复习
Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):511-3. doi: 10.1016/j.clml.2013.02.022. Epub 2013 May 29.
2
The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia.利妥昔单抗成功治疗慢性淋巴细胞白血病患者的难治性自身免疫性溶血性贫血。
Am J Hematol. 2006 Aug;81(8):631-3. doi: 10.1002/ajh.20671.
3
Management of autoimmune cytopenia complicating chronic lymphocytic leukemia.慢性淋巴细胞白血病并发自身免疫性血细胞减少的管理。
Leuk Lymphoma. 2009 Jun;50(6):863-4. doi: 10.1080/10428190902919226.
4
[Successful treatment with rituximab for autoimmune hemolytic anemia associated with chronic lymphocytic leukemia].利妥昔单抗成功治疗慢性淋巴细胞白血病相关的自身免疫性溶血性贫血
Rinsho Ketsueki. 2013 Feb;54(2):229-31.
5
Fludarabine-induced hemolytic anemia: successful treatment by rituximab.氟达拉滨诱导的溶血性贫血：利妥昔单抗成功治疗
Hematol J. 2004;5(1):81-3. doi: 10.1038/sj.thj.6200339.
6
Alemtuzumab to treat refractory autoimmune hemolytic anemia or thrombocytopenia in chronic lymphocytic leukemia.用阿仑单抗治疗慢性淋巴细胞白血病所致难治性自身免疫性溶血性贫血或血小板减少症。
Curr Hematol Malig Rep. 2009 Jan;4(1):47-53. doi: 10.1007/s11899-009-0007-4.
7
Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.基于利妥昔单抗的化疗用于慢性淋巴细胞白血病的类固醇难治性自身免疫性溶血性贫血
Leukemia. 2002 Oct;16(10):2092-5. doi: 10.1038/sj.leu.2402676.
8
Successful treatment of steroid and cyclophosphamide-resistant hemolysis in chronic lymphocytic leukemia with rituximab.
Am J Hematol. 2002 Mar;69(3):232-3. doi: 10.1002/ajh.10046.
9
Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.发生于B细胞慢性淋巴细胞白血病的氟达拉滨相关自身免疫性溶血性贫血。
Leuk Res. 2006 Dec;30(12):1589-90. doi: 10.1016/j.leukres.2006.02.011. Epub 2006 Mar 20.
10
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).苯达莫司汀和利妥昔单抗联合治疗慢性淋巴细胞白血病相关自身免疫性溶血性贫血：法国 CLL 协作组（GCFLLC/MW 和 GOELAMS）的一项多中心回顾性研究。
Am J Hematol. 2015 Mar;90(3):204-7. doi: 10.1002/ajh.23909. Epub 2015 Jan 16.

引用本文的文献

1
How I manage autoimmune cytopenias in patients with lymphoid cancer.我如何治疗淋巴癌患者的自身免疫性血细胞减少症。
Blood. 2022 Mar 10;139(10):1479-1488. doi: 10.1182/blood.2019003686.
2
Autoimmune hemolytic anemia: current knowledge and perspectives.自身免疫性溶血性贫血：当前的认识与展望
Immun Ageing. 2020 Nov 20;17(1):38. doi: 10.1186/s12979-020-00208-7.
3
Chronic Lymphocytic Leukemia Presenting as a Subcortical Watershed Infarct.表现为皮质下分水岭梗死的慢性淋巴细胞白血病
Case Rep Hematol. 2019 Jan 9;2019:2089359. doi: 10.1155/2019/2089359. eCollection 2019.
4
Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results.奥法木单抗联合糖皮质激素用于慢性移植物抗宿主病的初始治疗：I期试验结果
Biol Blood Marrow Transplant. 2015 Jun;21(6):1074-82. doi: 10.1016/j.bbmt.2015.03.014. Epub 2015 Mar 21.
5
Treatment of autoimmune hemolytic anemias.自身免疫性溶血性贫血的治疗。
Haematologica. 2014 Oct;99(10):1547-54. doi: 10.3324/haematol.2014.114561.